Correlation Between Esperion Therapeutics and SIGA Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and SIGA Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and SIGA Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and SIGA Technologies, you can compare the effects of market volatilities on Esperion Therapeutics and SIGA Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of SIGA Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and SIGA Technologies.

Diversification Opportunities for Esperion Therapeutics and SIGA Technologies

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Esperion and SIGA is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and SIGA Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIGA Technologies and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with SIGA Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIGA Technologies has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and SIGA Technologies go up and down completely randomly.

Pair Corralation between Esperion Therapeutics and SIGA Technologies

Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 1.14 times more return on investment than SIGA Technologies. However, Esperion Therapeutics is 1.14 times more volatile than SIGA Technologies. It trades about 0.09 of its potential returns per unit of risk. SIGA Technologies is currently generating about 0.05 per unit of risk. If you would invest  141.00  in Esperion Therapeutics on September 4, 2024 and sell it today you would earn a total of  184.00  from holding Esperion Therapeutics or generate 130.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Esperion Therapeutics  vs.  SIGA Technologies

 Performance 
       Timeline  
Esperion Therapeutics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
SIGA Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SIGA Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, SIGA Technologies is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Esperion Therapeutics and SIGA Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Esperion Therapeutics and SIGA Technologies

The main advantage of trading using opposite Esperion Therapeutics and SIGA Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, SIGA Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIGA Technologies will offset losses from the drop in SIGA Technologies' long position.
The idea behind Esperion Therapeutics and SIGA Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital